pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
1,486
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
savolitinib
Non-Small Cell Lung Cancer
Hepatocyte growth factor receptor
$AZN
ASTRAZENECA PLC
0
catalysts
Phase 2
secutrelvir
secutrelvir [INN]
Coronavirus Disease 2019 (COVID-19)
$SGIOF
SHIONOGI & CO LTD
0
catalysts
Phase 2
selcodebart
selcodebart [INN]
Anemia
$IRON
Disc Medicine, Inc.
catalysts
← prev
page 46 of 50
next →
131
Pain
89
Neurology
1
0
Phase 2
semzuvolimab
semzuvolimab [INN]
Human Immunodeficiency Virus (HIV) Infections (AIDS)
United BioPharma Inc
0
catalysts
Phase 2
sepantronium bromide
Burkitt Lymphoma
Beijing zhikangbo Medical Oncology Research Co Ltd
0
catalysts
Phase 2
sepetaprost
sepetaprost [INN]
Ocular Hypertension
Santen Pharmaceutical Co Ltd
0
catalysts
Phase 2
setanaxib
setanaxib [INN]
Primary Biliary Cholangitis (Primary Biliary Cirrhosis)
Calliditas Therapeutics AB
0
catalysts
Phase 2
seviprotimut-L
Melanoma
Polynoma LLC
0
catalysts
Phase 2
siG-12D-LODER
Pancreatic Ductal Adenocarcinoma
$SLXN
Silexion Therapeutics Corp
0
catalysts
Phase 2
silevertinib
Non-Small Cell Lung Cancer
$BDTX
Black Diamond Therapeutics, Inc.
0
catalysts
Phase 2
silmitasertib
silmitasertib [INN]
Bile Duct Cancer (Cholangiocarcinoma)
Senhwa Biosciences Inc
0
catalysts
Phase 2
sintilimab
Angiosarcoma
Programmed cell death protein 1
Innovent Biologics Inc
0
catalysts
Phase 2
sirexatamab
sirexatamab [INN]
Endometrial Cancer
Leap Therapeutics Inc
0
catalysts
Phase 2
sirpiglenastat
Metastatic Hepatocellular Carcinoma (HCC)
Dracen Pharmaceuticals Inc
0
catalysts
Phase 2
solbinsiran sodium
Mixed Dyslipidemia
Eli Lilly and Co
0
catalysts
Phase 2
solnerstotug
solnerstotug [INN]
Bile Duct Cancer (Cholangiocarcinoma)
$SNSE
Sensei Biotherapeutics, Inc.
0
catalysts
Phase 2
solrikitug
Asthma
Uniquity Bio Inc
0
catalysts
Phase 2
sonefpeglutide
sonefpeglutide [INN]
Short Bowel Syndrome
Hanmi Pharmaceuticals Co Ltd
0
catalysts
Phase 2
sonlicromanol
sonlicromanol [INN]
Subacute Necrotizing Encephalomyelopathy (Leigh Disease)
Khondrion BV
0
catalysts
Phase 2
sozinibercept
Diabetic Macular Edema
$CKDXF
Opthea Ltd
0
catalysts
Phase 2
spevatamig
Adenocarcinoma Of The Gastroesophageal Junction
Phanes Therapeutics Inc
0
catalysts
Phase 2
sugemalimab
Cejemly (sugemalimab [INN])
Natural Killer Cell Lymphomas
CStone Pharmaceuticals Co Ltd
0
catalysts
Phase 2
sunobinop tosylate
Alcohol Use Disorder (AUD)
Imbrium Therapeutics LP
0
catalysts
Phase 2
suratadenoturev
Telomelysin (suratadenoturev)
Adenocarcinoma Of The Gastroesophageal Junction
Oncolys BioPharma Inc
0
catalysts
Phase 2
surovatamig
surovatamig [INN]
B-Cell Non-Hodgkin Lymphoma
$AZN
ASTRAZENECA PLC
0
catalysts
Phase 2
surufatinib
Solid Tumor
Fibroblast growth factor receptor 1
Vascular endothelial growth factor receptor
$HCM
HUTCHMED (China) Ltd
0
catalysts
Phase 2
surzebiclimab
Recurrent Head And Neck Squamous Cell Carcinoma
$ONC
BeOne Medicines Ltd.
0
catalysts
Phase 2
sutacimig
sutacimig [INN]
Bleeding And Clotting Disorders
Hemab ApS
0
catalysts
Phase 2
suvratoxumab
Staphylococcus aureus Infections
Alpha-hemolysin
Aridis Pharmaceuticals Inc
0
catalysts
Phase 2
tagitanlimab
tagitanlimab [INN]
Nasopharyngeal Cancer
Hbm Holdings Ltd
0
catalysts
